Literature DB >> 19883775

Reduced frequency of regulatory T cells in peripheral blood stem cell compared to bone marrow transplantations.

Céline Blache1, Joe-Marc Chauvin, Aude Marie-Cardine, Nathalie Contentin, Pascal Pommier, Ingrid Dedreux, Stéphanie François, Serge Jacquot, Dominique Bastit, Olivier Boyer.   

Abstract

Peripheral blood stem cell transplantation (PBSCT) is an alternative to bone marrow transplantation (BMT). Although CD4(+)CD25(+)CD127(lo) regulatory T cells (Tregs) have been shown to play important roles in the control of T cell reactivity, the Treg contents of both graft types have not been analyzed comparatively to date. We report herein that Treg frequencies are significantly reduced in PBSC compared to BM transplants. Furthermore, most Tregs from PBSC transplants are CD62L(lo), a phenotype reported to have poor suppressor activity. Both granulocyte-colony stimulating factor (G-CSF) administration and leukapheresis were found to contribute to the loss of CD62L(+) Tregs. Although higher T cell numbers are infused in PBSCT than in BMT, it is possible that the reduced Treg content of PBSC transplants may represent 1 factor contributing to the higher risk of GVHD reported after PBSCT. Copyright (c) 2010 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19883775     DOI: 10.1016/j.bbmt.2009.10.027

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  12 in total

1.  Cytomegalovirus viral load and virus-specific immune reconstitution after peripheral blood stem cell versus bone marrow transplantation.

Authors:  Abraham Guerrero; Stanley R Riddell; Jan Storek; Terry Stevens-Ayers; Barry Storer; John A Zaia; Stephen Forman; Robert S Negrin; Thomas Chauncey; William Bensinger; Michael Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2011-05-20       Impact factor: 5.742

Review 2.  Therapeutic use of regulatory T cells for graft-versus-host disease.

Authors:  Shlomo Elias; Alexander Y Rudensky
Journal:  Br J Haematol       Date:  2019-08-16       Impact factor: 6.998

3.  Characterization of murine non-adherent bone marrow cells leading to recovery of endogenous hematopoiesis.

Authors:  Stephan Fricke; Christian Fricke; Christopher Oelkrug; Nadja Hilger; Uta Schönfelder; Manja Kamprad; Jörg Lehmann; Johannes Boltze; Frank Emmrich; Ulrich Sack
Journal:  Cell Mol Life Sci       Date:  2010-06-18       Impact factor: 9.261

4.  Simultaneous bone marrow and composite tissue transplantation in rats treated with nonmyeloablative conditioning promotes tolerance.

Authors:  Hong Xu; Deborah M Ramsey; Shengli Wu; Larry D Bozulic; Suzanne T Ildstad
Journal:  Transplantation       Date:  2013-01-27       Impact factor: 4.939

5.  The role of regulatory T cells in the biology of graft versus host disease.

Authors:  Amy J Beres; William R Drobyski
Journal:  Front Immunol       Date:  2013-06-24       Impact factor: 7.561

6.  Higher frequency of regulatory T cells in granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts compared with G-CSF-primed peripheral blood grafts.

Authors:  Xiang-Yu Zhao; Yu-Tong Wang; Xiao-Dong Mo; Xiao-Su Zhao; Ya-Zhe Wang; Ying-Jun Chang; Xiao-Jun Huang
Journal:  J Transl Med       Date:  2015-05-07       Impact factor: 5.531

7.  The Migratory Properties and Numbers of T Regulatory Cell Subsets in Circulation Are Differentially Influenced by Season and Are Associated With Vitamin D Status.

Authors:  Abigail A Lamikanra; Hoi Pat Tsang; Shaza Elsiddig; Michael Spencer; Elinor Curnow; Robert Danby; David J Roberts
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

8.  A Comparison of Automated Perfusion- and Manual Diffusion-Based Human Regulatory T Cell Expansion and Functionality Using a Soluble Activator Complex.

Authors:  Mark Jones; Brian Nankervis; Kelly Santos Roballo; Huong Pham; Jared Bushman; Claire Coeshott
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

9.  Clinical factors influencing phenotype of HCMV-specific CD8+ T cells and HCMV-induced interferon-gamma production after allogeneic stem cells transplantation.

Authors:  Inmaculada Gayoso; Sara Cantisán; Carolina Cerrato; Joaquín Sánchez-García; Carmen Martin; Rafael Solana; Antonio Torres-Gomez; Julian Torre-Cisneros
Journal:  Clin Dev Immunol       Date:  2013-02-02

10.  High preharvest donor Foxp3 mRNA level predicts late relapse of acute lymphoblastic leukaemia after haematopoietic stem cell transplantation.

Authors:  Niels Jacobsen; Tina Frisch; Niels Keiding; Carsten Heilmann; Henrik Sengeløv; Hans O Madsen; Hanne Marquart; Ebbe Dickmeiss; Mette K Andersen; Claus B Christiansen; Lars P Ryder
Journal:  Eur J Haematol       Date:  2021-02-15       Impact factor: 2.997

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.